Literature DB >> 7626353

Beta adrenoceptor density in the donor heart: a guide to prognosis?

M R Chester1, A A Amadi, D B Barnett.   

Abstract

BACKGROUND: Failure of the donor (graft) heart is the main cause of mortality in the first month after orthotopic cardiac transplantation. In a preliminary study marked downregulation of cardiac beta adrenoceptor density was found in apparently normal donor hearts of recipients who developed severe cardiac failure soon after implantation. Cardiac beta adrenoceptors are an important factor in the development of cardiac failure in the human heart. The aim of this study therefore was to determine whether fatal graft failure in the first month after transplantation is associated with downregulation of beta adrenoceptor density in the donor heart. PATIENTS AND METHODS: Right ventricular endomyocardial biopsy specimens were taken from consecutive adult donor patients immediately before implantation. A previously described radioligand binding method was used to determine beta adrenoceptor density in consecutive patients who developed fatal graft failure and died within 1 month of transplantation and in a group of control donors transplanted during the same period.
RESULTS: Perioperative fatal graft failure developed in 13 patients. Forty one specimens from donor hearts that were transplanted into recipients who did not develop fatal graft heart failure formed the control group. There were no systematic differences in donor or recipient characteristics between the graft heart failure and control groups. In particular donor catecholamine requirement and recipient pulmonary vascular resistance did not differ between groups. Total beta adrenoceptor density was reduced in the fatal graft heart failure group compared with that in the controls (13.4 (7) fmol/mg v 21 (7) fmol/mg; P < 0.01). There was a positive correlation between beta adrenoceptor density in the donor heart and time to death in the graft heart failure group (r2 = 0.3, P < 0.05). The beta adrenoceptor binding affinity (Kd) did not differ between the graft failure group and the controls (47 (6) pM v 44 (7) pM).
CONCLUSION: The development of perioperative fatal cardiac failure after orthotopic cardiac transplantation is associated with downregulation of beta adrenoceptors in the donor heart before implantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626353      PMCID: PMC483916          DOI: 10.1136/hrt.73.6.540

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  Subendocardial haemorrhages associated with intracranial lesions.

Authors:  R P SMITH; B E TOMLINSON
Journal:  J Pathol Bacteriol       Date:  1954-10

2.  The Registry of the International Society for Heart Transplantation: seventh official report--1990.

Authors:  J M Kriett; M P Kaye
Journal:  J Heart Transplant       Date:  1990 Jul-Aug

3.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.

Authors:  M R Bristow; R E Hershberger; J D Port; W Minobe; R Rasmussen
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

4.  Quantitative evaluation of myocardial injury induced by acute cerebral ischaemia and its prevention by beta 1-adrenergic blockade. An ultrastructural morphometry study.

Authors:  A Kolin; A Brezina; A J Lewis; J W Norris
Journal:  Br J Exp Pathol       Date:  1989-12

5.  Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts.

Authors:  A R Denniss; J D Marsh; R J Quigg; J B Gordon; W S Colucci
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

6.  Heart damage associated with intracranial lesions.

Authors:  R C Connor
Journal:  Br Med J       Date:  1968-07-06

7.  Biopsy assessment of fifty hearts during transplantation.

Authors:  S Darracott-Cankovíc; D Wheeldon; R Cory-Pearce; J Wallwork; T A English
Journal:  J Thorac Cardiovasc Surg       Date:  1987-01       Impact factor: 5.209

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol.

Authors:  R Ginsburg; M R Bristow; M E Billingham; E B Stinson; J S Schroeder; D C Harrison
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

10.  Plasma norepinephrine in stroke.

Authors:  M G Myers; J W Norris; V C Hachniski; M J Sole
Journal:  Stroke       Date:  1981 Mar-Apr       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.